gethi 75 mikrogramov/20 mikrogramov obložene tablete
obložena tableta - gestoden in etinilestradiol
parofor crypto ovce,koze -dcp
huvepharma nv uitbreidingstraat 80 2600 antwerpen belgija proizvajalec odgovoren za sproščanje serij: biovet jsc petar rakov street 39 4550 peštera bolgarija 2 -
forceris
ceva santé animale - toltrazuril, železo (iii) ion - toltrazuril, kombinacije - prašiči (pujski) - za hkratni preprečevanje pomanjkanja železa anemija in preprečevanju kliničnih znakov coccidiosis (driska), kot tudi zmanjšanje oocyst izločanje, v pujski na kmetijah z potrjena zgodovina coccidiosis zaradi cystoisospora suis.
nuedexta
jenson pharmaceutical services limited - dextromethorphan, quinidine - nevrološke manifestacije - druga zdravila na živčnem sistemu - zdravilo nuedexta je indicirano za simptomatsko zdravljenje pseudobulbarnega vpliva (pba) pri odraslih. učinkovitost so raziskali samo pri bolnikih z osnovno amiotrofično lateralno sklerozo ali multiplo sklerozo.
virbagen omega
virbac s.a. - rekombinantni omega interferon mačjega izvora - immunostimulants, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. pri mačkah, okuženih s fiv, je bila smrtnost nizka (5%) in na zdravljenje ni vplivala.
sebacil
bayer animal health gmbh -
byemite
bayer animal health gmbh 51368 leverkusen nemčija proizvajalec -
fluarix tetra suspenzija za injiciranje v napolnjeni injekcijski brizgi
ha seva b/phuket/3073/2013, divji tip, podoben sevu b/phuket/3073/2013; ha seva a/darwin/6/2021, ivr-227, podoben sevu a/darwin/9/2021 (h3n2); ha seva b/austria/1359417/2021, bvr-26, podoben sevu b/austria/1359417/2021; ha seva a/victoria/2897/2022, ivr-238, podoben sevu a/victoria/4897/2022 (h1n1)p - suspenzija za injiciranje v napolnjeni injekcijski brizgi - ha seva b/phuket/3073/2013, divji tip, podoben sevu b/phuket/3073/2013 15 µg / 0,5 ml ha seva a/darwin/6/2021, ivr-227, podoben sevu a/darwin/9/2021 (h3n2)15 µg / 0,5 ml ha seva b/austria/1359417/2021, bvr-26, podoben sevu b/austria/1359417/202115 µg / 0,5 ml ha seva a/victoria/2897/2022, ivr-238, podoben sevu a/victoria/4897/2022 (h1n1)p15 µg / 0,5 ml; ha seva a/darwin/6/2021, ivr-227, podoben sevu a/darwin/9/2021 (h3n2) 15 µg / 0,5 ml ha seva b/austria/1359417/2021, bvr-26, podoben sevu b/austria/1359417/202115 µg / 0,5 ml ha seva a/victoria/2897/2022, ivr-238, podoben sevu a/victoria/4897/2022 (h1n1)p15 µg / 0,5 ml; ha seva b/austria/1359417/2021, bvr-26, podoben sevu b/austria/1359417/2021 15 µg / 0,5 ml ha seva a/victoria/2897/2022, ivr-238, podoben sevu a/victoria/4897/2022 (h1n1)p15 µg / 0,5 ml; ha seva a/victoria/2897/2022, ivr-238, podoben sevu a/victoria/4897/2022 (h1n1)p - cepivo proti gripi, z delci virusov ali s površinskimi antigeni, inaktivirano
zerbaxa
merck sharp & dohme b.v. - ceftolozane sulfat, tazobactam natrijev - bakterijske okužbe - antibacterials za sistemsko uporabo, - zerbaxa is indicated for the treatment of the following infections in adults:complicated intra abdominal infections;acute pyelonephritis;complicated urinary tract infections;hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap). upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.
sumatriptan aurobindo 100 mg tablete
aurobindo pharma limited - sumatriptan - tableta - sumatriptan 100 mg / 1 tableta - sumatriptan